Currently out of the existing stock ratings of Michael Polark, 1870 are a BUY (75.46%), 595 are a HOLD (24.01%), 13 are a SELL (0.52%).

Michael Polark

Work Performance Price Targets & Ratings Chart

Analyst Michael Polark, currently employed at WOLFE, carries an average stock price target met ratio of 59.17% that have a potential upside of 9.84% achieved within 89 days. Previously, Michael Polark worked at BAIRD.

Michael Polark’s has documented 107 price targets and ratings displayed on 17 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on MASI, Masimo at 15-Sep-2022.

Wall Street Analyst Michael Polark

Analyst best performing recommendations are on NVRO (NEVRO CORP).
The best stock recommendation documented was for NVRO (NEVRO CORP) at 4/6/2022. The price target of $64 was fulfilled within 23 days with a profit of $11.91 (15.69%) receiving and performance score of 6.82.

Average potential price target upside

of $27.46 (14.52%) on STE (STERIS PLC).
of $25.47 (14.87%) on MASI (MASIMO).
of $13.3 (12.44%) on HRC (HILL-ROM HOLDINGS).

AXNX Axonics Modulation Technologies HRC Hill-Rom Holdings ISRG Intuitive Surgical NVRO Nevro Corp RMD ResMed SHC Sotera Health Co STE STERIS plc INSP Inspire Medical Systems LIVN LivaNova PLC NPCE Neuropace IRT Independence Realty Trust VCRA Vocera Communications ABMD ABIOMED MASI Masimo SILK Silk Road Medical NYXH Nyxoah SWAV Shockwave Medical

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Mike Matson (NEEDHAM)